Protagonist Therapeutics to Current on the forty first Annual J.P. Morgan Healthcare Convention
NEWARK, Calif., Dec. 21, 2022 /PRNewswire/ — Protagonist Therapeutics, Inc. (Nasdaq: PTGX) (“Protagonist” or “the
NEWARK, Calif., Dec. 21, 2022 /PRNewswire/ — Protagonist Therapeutics, Inc. (Nasdaq: PTGX) (“Protagonist” or “the